NYSE - Delayed Quote USD
Bristol-Myers Squibb Company (BMY)
47.62
+0.05
+(0.11%)
At close: May 7 at 4:00:02 PM EDT
46.90
-0.72
(-1.51%)
After hours: May 7 at 7:57:31 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 17 | 25 | 26 |
| Avg. Estimate | 1.68 | 1.73 | 6.87 | 6.08 |
| Low Estimate | 1.52 | 1.66 | 6.71 | 5.09 |
| High Estimate | 1.76 | 1.87 | 7 | 6.7 |
| Year Ago EPS | 2.07 | 1.8 | 1.15 | 6.87 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 15 | 25 | 26 |
| Avg. Estimate | 11.32B | 11.64B | 46.17B | 42.99B |
| Low Estimate | 11.11B | 11.49B | 45.62B | 40.92B |
| High Estimate | 11.57B | 11.76B | 46.63B | 44.67B |
| Year Ago Sales | 12.2B | 11.89B | 48.3B | 46.17B |
| Sales Growth (year/est) | -7.24% | -2.12% | -4.41% | -6.88% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 1.63 | 1.5 | 1.47 | 1.5 |
| EPS Actual | 2.07 | 1.8 | 1.67 | 1.8 |
| Difference | 0.44 | 0.3 | 0.2 | 0.3 |
| Surprise % | 27.37% | 19.98% | 13.80% | 19.88% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.68 | 1.73 | 6.87 | 6.08 |
| 7 Days Ago | 1.68 | 1.73 | 6.87 | 6.08 |
| 30 Days Ago | 1.7 | 1.74 | 6.76 | 6.15 |
| 60 Days Ago | 1.7 | 1.74 | 6.75 | 6.15 |
| 90 Days Ago | 1.83 | 1.81 | 6.91 | 6.22 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 5 | 19 | 11 |
| Up Last 30 Days | 4 | 6 | 17 | 7 |
| Down Last 7 Days | 10 | 6 | 2 | 8 |
| Down Last 30 Days | 10 | 6 | 3 | 13 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BMY | -18.85% | -4.07% | 497.40% | -11.53% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 4/23/2025 |
| Maintains | Jefferies: Buy to Buy | 4/23/2025 |
| Initiated | Piper Sandler: Overweight | 4/22/2025 |
| Maintains | UBS: Neutral to Neutral | 4/11/2025 |
| Downgrade | Goldman Sachs: Buy to Neutral | 4/8/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/7/2025 |
Related Tickers
MRK Merck & Co., Inc.
79.12
+0.10%
PFE Pfizer Inc.
22.79
-0.39%
ABBV AbbVie Inc.
188.09
+0.50%
JNJ Johnson & Johnson
157.30
+1.83%
AMGN Amgen Inc.
275.84
+2.00%
GILD Gilead Sciences, Inc.
98.90
+1.04%
OGN Organon & Co.
8.76
-4.05%
GSK GSK plc
37.17
-0.88%
LLY Eli Lilly and Company
776.72
+0.21%
NVO Novo Nordisk A/S
67.55
+1.90%